SMP-93566
SMP-93566 is a kind of antibody-drug conjugates (ADCs) with a low payload shedding rate and has in vivo tumor inhibitory effects on ovarian cancer, gastric cancer, and breast cancer.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3055605-39-2
- Formel: C72H100N8O21
- Molecular Weight:1413.61
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Drug-Linker Conjugates for ADC Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
In Vitro
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 3055605-39-2
-
Molecular Weight 1413.61
-
Formel C72H100N8O21
-
SMILES
O=C(NC[C@@H](O)C[C@H]1O[C@@H](C[C@H]2O[C@@H](CC[C@H]3C(C[C@H](CC[C@]45C[C@](O6)([H])[C@@H]7O4)O3)=C)C[C@@H](C)C2=C)[C@H](CC(C[C@H]8CC[C@@]9([H])[C@]([C@H](O5)C6C7O9)([H])O8)=O)[C@H]1OC)CNC([C@H](CC%10=CC=CC=C%10)NC(CNC(CNC(CN%11CCOCCN(C(CCN%12C(C=CC%12=O)=O)=O)CCOCC%11)=O)=O)=O)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
Reinheit & Dokumentation
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)